Skip to content

Construction and Clinical Validation of an Intelligent Diagnostic Model for Diabetes Based on Integrated Chinese and Western Medicine

Construction and Clinical Validation of an Intelligent Diagnostic Model for Diabetes Based on Integrated Chinese and Western Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121862
Enrollment
Unknown
Registered
2026-04-06
Start date
2026-04-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-diabetes (or type 2 diabetes)

Interventions

Pre-diabetes (or type 2 diabetes) observation group:None
Control group:None

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 80 years old; 2. Participants who voluntarily participate in this study and sign the informed consent form. 3. Inclusion criteria for the experimental group: In addition to the basic conditions, the following conditions must also be met: fasting blood glucose (FPG) >= 6.1 mmol/L, or 2-hour blood glucose after oral glucose tolerance test (OGTT) >= 7.8 mmol/L, or glycosylated hemoglobin (HbA1c) >= 5.7%. Inclusion criteria for the control group: In addition to the basic conditions, the fasting blood glucose, 2-hour blood glucose after OGTT, and HbA1c must all be lower than the above standards, and there must be no history of diabetes or abnormal glucose tolerance.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver and kidney dysfunction, tumors, cerebrovascular diseases, blood disorders, thyroid diseases; 2. Pregnant or suspected pregnant women, with unexplained vaginal bleeding; 3. Patients with severe mental and psychological disorders; 4. Those who cannot cooperate for tongue diagnosis and photography due to surgery, trauma, etc.; 5. Other researchers consider not suitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose (FBG);Glycated hemoglobin;Hyperspectral tongue imaging data;

Countries

China

Contacts

Public ContactXinli Yang

Beijing Friendship Hospital, Capital Medical University

selenemola@126.com+86 186 1108 6309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026